{"id":"https://openalex.org/W2906800538","doi":"https://doi.org/10.1182/blood-2018-99-113299","title":"Role of Measurable Residual Disease (MRD) in Redefining Complete Response (CR) in Elderly Patients with Acute Myeloid Leukemia (AML): Results from the Pethema-Flugaza Phase III Clinical Trial","display_name":"Role of Measurable Residual Disease (MRD) in Redefining Complete Response (CR) in Elderly Patients with Acute Myeloid Leukemia (AML): Results from the Pethema-Flugaza Phase III Clinical Trial","publication_year":2018,"publication_date":"2018-11-29","ids":{"openalex":"https://openalex.org/W2906800538","doi":"https://doi.org/10.1182/blood-2018-99-113299","mag":"2906800538"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2018-99-113299","doi":"https://doi.org/10.1182/blood-2018-99-113299","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-113299","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057189669","display_name":"Bruno Paiva","orcid":"https://orcid.org/0000-0003-1977-3815","observed_orcids":["https://orcid.org/0000-0003-1977-3815","https://orcid.org/0000-0002-0128-8849"]},"institutions":[{"id":"https://openalex.org/I4210135003","display_name":"Clinica Universidad de Navarra","ror":"https://ror.org/03phm3r45","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210135003"]},{"id":"https://openalex.org/I4210158561","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","ror":"https://ror.org/04hya7017","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210158561"]},{"id":"https://openalex.org/I4392738196","display_name":"Centro de Investigaci\u00f3n M\u00e9dica Aplicada","ror":"https://ror.org/01qew8q20","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4392738196","https://openalex.org/I88155538"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Bruno Paiva","raw_affiliation_strings":["Cl\u00ednica Universidad de Navarra, Centro de Investigaci\u00f3n M\u00e9dica Aplicada (CIMA), IDISNA, CIBERONC, Pamplona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cl\u00ednica Universidad de Navarra, Centro de Investigaci\u00f3n M\u00e9dica Aplicada (CIMA), IDISNA, CIBERONC, Pamplona, Spain","institution_ids":["https://openalex.org/I4210135003","https://openalex.org/I4210158561","https://openalex.org/I4392738196"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011914281","display_name":"David Mart\u00ednez\u2010Cuadr\u00f3n","orcid":"https://orcid.org/0000-0001-7540-4091","observed_orcids":["https://orcid.org/0000-0001-7540-4091"]},"institutions":[{"id":"https://openalex.org/I3019010403","display_name":"Hospital Universitari i Polit\u00e8cnic La Fe","ror":"https://ror.org/01ar2v535","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I3019010403","https://openalex.org/I4210166036"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"David Mart\u00ednez-Cuadron","raw_affiliation_strings":["Hospital Universitari i Polit\u00e8cnic La Fe, Valencia, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitari i Polit\u00e8cnic La Fe, Valencia, Spain","institution_ids":["https://openalex.org/I3019010403"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032225567","display_name":"Juan Miguel Bergua Burgu\u00e9s","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111317","display_name":"Hospital San Pedro de Alc\u00e1ntara","ror":"https://ror.org/01yp8kc21","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210111317"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Juan Miguel Miguel Bergua Burgues","raw_affiliation_strings":["Hospital San Pedro de Alc\u00e1ntara, Caceres, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital San Pedro de Alc\u00e1ntara, Caceres, Spain","institution_ids":["https://openalex.org/I4210111317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089534178","display_name":"Susana Vives","orcid":"https://orcid.org/0000-0003-2217-5285","observed_orcids":["https://orcid.org/0000-0003-2217-5285"]},"institutions":[{"id":"https://openalex.org/I4210153460","display_name":"Hospital Universitari Germans Trias i Pujol","ror":"https://ror.org/04wxdxa47","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210153292","https://openalex.org/I4210153460"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Susana Vives","raw_affiliation_strings":["Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain","institution_ids":["https://openalex.org/I4210153460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051446836","display_name":"Jes\u00fas Lorenzo Algarra","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210145506","display_name":"Hospital General Universitario de Albacete","ror":"https://ror.org/055p2yz63","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210141158","https://openalex.org/I4210145506","https://openalex.org/I4210155114"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Jes\u00fas Lorenzo Algarra","raw_affiliation_strings":["Hospital General de Albacete, Albacete, ESP"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital General de Albacete, Albacete, ESP","institution_ids":["https://openalex.org/I4210145506"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Mar Tormo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094406","display_name":"Hospital Cl\u00ednico Universitario de Valencia","ror":"https://ror.org/00hpnj894","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210094406"]},{"id":"https://openalex.org/I4210158373","display_name":"INCLIVA Health Research Institute","ror":"https://ror.org/059wbyv33","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210158373"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Mar Tormo","raw_affiliation_strings":["Hematology Department, Hospital Cl\u00ednico Universitario, Instituto de investigacion INCLIVA, Valencia, Valencia, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Department, Hospital Cl\u00ednico Universitario, Instituto de investigacion INCLIVA, Valencia, Valencia, Spain","institution_ids":["https://openalex.org/I4210094406","https://openalex.org/I4210158373"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002155891","display_name":"Pilar Mart\u00ednez\u2010S\u00e1nchez","orcid":"https://orcid.org/0000-0002-7334-140X","observed_orcids":["https://orcid.org/0000-0002-7334-140X"]},"institutions":[{"id":"https://openalex.org/I4210101691","display_name":"Hospital Universitario 12 De Octubre","ror":"https://ror.org/00qyh5r35","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210101691","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Pilar Mart\u00ednez-S\u00e1nchez","raw_affiliation_strings":["Hospital Universitario 12 de Octubre, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario 12 de Octubre, Madrid, Spain","institution_ids":["https://openalex.org/I4210101691"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052872662","display_name":"Josefina Serrano","orcid":"https://orcid.org/0000-0003-1608-6016","observed_orcids":["https://orcid.org/0000-0003-1608-6016","https://orcid.org/0009-0004-7046-8722"]},"institutions":[{"id":"https://openalex.org/I4210123675","display_name":"Hospital Universitario Reina Sof\u00eda","ror":"https://ror.org/02vtd2q19","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I158283456","https://openalex.org/I4210123675"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Josefina Serrano","raw_affiliation_strings":["University Hospital Reina Sofia, Cordoba, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital Reina Sofia, Cordoba, Spain","institution_ids":["https://openalex.org/I4210123675"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053626099","display_name":"Pilar Herrera","orcid":"https://orcid.org/0000-0002-4118-7110","observed_orcids":["https://orcid.org/0000-0002-4118-7110"]},"institutions":[{"id":"https://openalex.org/I4210161852","display_name":"Hospital Universitario Ram\u00f3n y Cajal","ror":"https://ror.org/050eq1942","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210139293","https://openalex.org/I4210161852"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Pilar Herrera","raw_affiliation_strings":["Hospital Universitario Ram\u00f3n y Cajal, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario Ram\u00f3n y Cajal, Madrid, Spain","institution_ids":["https://openalex.org/I4210161852"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055139947","display_name":"Fernando Ramos","orcid":"https://orcid.org/0000-0002-4991-2655","observed_orcids":["https://orcid.org/0000-0002-4991-2655"]},"institutions":[{"id":"https://openalex.org/I4210160075","display_name":"Hospital Universitario de Le\u00f3n","ror":"https://ror.org/05gn84d31","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210160075"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Fernando Ramos","raw_affiliation_strings":["Instituto de Biomedicina (IBIOMED), Hospital Universitario de Le\u00f3n, L\u00e9on, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto de Biomedicina (IBIOMED), Hospital Universitario de Le\u00f3n, L\u00e9on, Spain","institution_ids":["https://openalex.org/I4210160075"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006887524","display_name":"Olga Salamero","orcid":"https://orcid.org/0000-0003-3237-0025","observed_orcids":["https://orcid.org/0000-0003-3237-0025"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Olga Salamero","raw_affiliation_strings":["Vall d'Hebron University Hospital, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vall d'Hebron University Hospital, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009262129","display_name":"Esperanza Lavilla","orcid":"https://orcid.org/0000-0003-1490-0678","observed_orcids":["https://orcid.org/0000-0003-1490-0678"]},"institutions":[{"id":"https://openalex.org/I4210145084","display_name":"Hospital Universitario Lucus Augusti","ror":"https://ror.org/0416des07","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210145084"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Esperanza Lavilla","raw_affiliation_strings":["Hospital Lucus Augusti, Lugo, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Lucus Augusti, Lugo, Spain","institution_ids":["https://openalex.org/I4210145084"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036778361","display_name":"Cristina Gil","orcid":"https://orcid.org/0000-0002-5062-2364","observed_orcids":["https://orcid.org/0000-0002-5062-2364"]},"institutions":[{"id":"https://openalex.org/I4210137674","display_name":"Hospital General Universitario de Alicante Doctor Balmis","ror":"https://ror.org/02ybsz607","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210137674"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Cristina Gil","raw_affiliation_strings":["Hospital General Universitario de Alicante, Alicante, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital General Universitario de Alicante, Alicante, Spain","institution_ids":["https://openalex.org/I4210137674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059420340","display_name":"Jos\u00e9 Luis L\u00f3pez Lorenzo","orcid":"https://orcid.org/0000-0003-1502-3902","observed_orcids":["https://orcid.org/0000-0003-1502-3902"]},"institutions":[{"id":"https://openalex.org/I4210129357","display_name":"Hospital Universitario Fundaci\u00f3n Jim\u00e9nez D\u00edaz","ror":"https://ror.org/049nvyb15","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210129357"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Jose Luiz Lopez Lorenzo","raw_affiliation_strings":["Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid, Spain","institution_ids":["https://openalex.org/I4210129357"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069753479","display_name":"Mar\u00eda\u2010Bel\u00e9n V\u00eddriales","orcid":"https://orcid.org/0000-0001-5049-3673","observed_orcids":["https://orcid.org/0000-0001-5049-3673"]},"institutions":[{"id":"https://openalex.org/I4210099034","display_name":"Complejo Hospitalario de Salamanca","ror":"https://ror.org/0131vfw26","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I184999862","https://openalex.org/I4210099034"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Maria-Belen Vidriales","raw_affiliation_strings":["Hospital Universitario Salamanca, Salamanca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario Salamanca, Salamanca, Spain","institution_ids":["https://openalex.org/I4210099034"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025193090","display_name":"Jorge Labrador","orcid":"https://orcid.org/0000-0002-3696-0287","observed_orcids":["https://orcid.org/0000-0002-3696-0287"]},"institutions":[{"id":"https://openalex.org/I4210115949","display_name":"Hospital Universitario de Burgos","ror":"https://ror.org/01j5v0d02","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210115949"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Jorge Labrador","raw_affiliation_strings":["Hospital Universitario de Burgos, Burgos, ESP"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario de Burgos, Burgos, ESP","institution_ids":["https://openalex.org/I4210115949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019086598","display_name":"Jose Francisco Falantes","orcid":"https://orcid.org/0000-0001-8660-7038","observed_orcids":["https://orcid.org/0000-0001-8660-7038"]},"institutions":[{"id":"https://openalex.org/I4210133602","display_name":"Instituto de Biomedicina de Sevilla","ror":"https://ror.org/031zwx660","country_code":"ES","type":"facility","lineage":["https://openalex.org/I134820265","https://openalex.org/I158283456","https://openalex.org/I4210133602","https://openalex.org/I79238269","https://openalex.org/I918821925"]},{"id":"https://openalex.org/I4210153139","display_name":"Hospital Universitario Virgen del Roc\u00edo","ror":"https://ror.org/04vfhnm78","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210153139"]},{"id":"https://openalex.org/I79238269","display_name":"Universidad de Sevilla","ror":"https://ror.org/03yxnpp24","country_code":"ES","type":"education","lineage":["https://openalex.org/I79238269"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Jos\u00e9 F. Falantes","raw_affiliation_strings":["Department of Hematology, Hospital Universitario Virgen del Roc\u00edo; Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Universidad de Sevilla, Seville, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Hospital Universitario Virgen del Roc\u00edo; Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Universidad de Sevilla, Seville, Spain","institution_ids":["https://openalex.org/I4210133602","https://openalex.org/I4210153139","https://openalex.org/I79238269"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111830456","display_name":"Mar\u00eda Jos\u00e9 Sayas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126200","display_name":"Hospital Universitario Doctor Peset","ror":"https://ror.org/03971n288","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210126200"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Maria Jose Sayas","raw_affiliation_strings":["Hospital Universitario Doctor Peset, Valencia, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario Doctor Peset, Valencia, Spain","institution_ids":["https://openalex.org/I4210126200"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113503287","display_name":"Juana Merino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210135003","display_name":"Clinica Universidad de Navarra","ror":"https://ror.org/03phm3r45","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210135003"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Juana Merino","raw_affiliation_strings":["Clinica Universidad de Navarra, Pamplona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinica Universidad de Navarra, Pamplona, Spain","institution_ids":["https://openalex.org/I4210135003"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034579404","display_name":"Ana Alfonso Pi\u00e9rola","orcid":"https://orcid.org/0000-0002-2478-5354","observed_orcids":["https://orcid.org/0000-0002-2478-5354"]},"institutions":[{"id":"https://openalex.org/I4210135003","display_name":"Clinica Universidad de Navarra","ror":"https://ror.org/03phm3r45","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210135003"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Ana Alfonso","raw_affiliation_strings":["Clinica Universidad de Navarra, Pamplona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinica Universidad de Navarra, Pamplona, Spain","institution_ids":["https://openalex.org/I4210135003"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016030888","display_name":"Felipe Pr\u00f3sper","orcid":"https://orcid.org/0000-0001-6115-8790","observed_orcids":["https://orcid.org/0000-0001-6115-8790"]},"institutions":[{"id":"https://openalex.org/I4210135003","display_name":"Clinica Universidad de Navarra","ror":"https://ror.org/03phm3r45","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210135003"]},{"id":"https://openalex.org/I4392738196","display_name":"Centro de Investigaci\u00f3n M\u00e9dica Aplicada","ror":"https://ror.org/01qew8q20","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4392738196","https://openalex.org/I88155538"]},{"id":"https://openalex.org/I88155538","display_name":"Universidad de Navarra","ror":"https://ror.org/02rxc7m23","country_code":"ES","type":"education","lineage":["https://openalex.org/I88155538"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Felipe Prosper","raw_affiliation_strings":["Centro de Investigaci\u00f3n M\u00e9dica Aplicada, University of Navarra, Clinica Universidad de Navarra, Pamplona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro de Investigaci\u00f3n M\u00e9dica Aplicada, University of Navarra, Clinica Universidad de Navarra, Pamplona, Spain","institution_ids":["https://openalex.org/I4210135003","https://openalex.org/I4392738196","https://openalex.org/I88155538"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020989412","display_name":"Jes\u00fas F. San Miguel","orcid":"https://orcid.org/0000-0002-9183-4857","observed_orcids":["https://orcid.org/0000-0002-9183-4857"]},"institutions":[{"id":"https://openalex.org/I4210135003","display_name":"Clinica Universidad de Navarra","ror":"https://ror.org/03phm3r45","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210135003"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jesus F San-Miguel","raw_affiliation_strings":["Clinica Universidad de Navarra, Pamplona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinica Universidad de Navarra, Pamplona, Spain","institution_ids":["https://openalex.org/I4210135003"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017341923","display_name":"Miguel \u00c1ngel Sanz","orcid":"https://orcid.org/0000-0003-1489-1177","observed_orcids":["https://orcid.org/0000-0003-1489-1177"]},"institutions":[{"id":"https://openalex.org/I3019010403","display_name":"Hospital Universitari i Polit\u00e8cnic La Fe","ror":"https://ror.org/01ar2v535","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I3019010403","https://openalex.org/I4210166036"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Miguel A. Sanz","raw_affiliation_strings":["Servicio de Hematolog\u00eda. Hospital La Fe, Valencia, Spain, Valencia, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servicio de Hematolog\u00eda. Hospital La Fe, Valencia, Spain, Valencia, Spain","institution_ids":["https://openalex.org/I3019010403"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5003682435","display_name":"Pau Montesinos","orcid":"https://orcid.org/0000-0002-3275-5593","observed_orcids":["https://orcid.org/0000-0002-3275-5593"]},"institutions":[{"id":"https://openalex.org/I3019010403","display_name":"Hospital Universitari i Polit\u00e8cnic La Fe","ror":"https://ror.org/01ar2v535","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I3019010403","https://openalex.org/I4210166036"]},{"id":"https://openalex.org/I4210158561","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","ror":"https://ror.org/04hya7017","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210158561"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Pau Montesinos","raw_affiliation_strings":["Hospital Universitari i Polit\u00e8cnic La Fe, Valencia; CIBERONC, Instituto Carlos III, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitari i Polit\u00e8cnic La Fe, Valencia; CIBERONC, Instituto Carlos III, Madrid, Spain","institution_ids":["https://openalex.org/I3019010403","https://openalex.org/I4210158561"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":24,"corresponding_author_ids":["https://openalex.org/A5002155891","https://openalex.org/A5003682435","https://openalex.org/A5006887524","https://openalex.org/A5009262129","https://openalex.org/A5011914281","https://openalex.org/A5016030888","https://openalex.org/A5019086598","https://openalex.org/A5025193090","https://openalex.org/A5032225567","https://openalex.org/A5034579404","https://openalex.org/A5036778361","https://openalex.org/A5051446836","https://openalex.org/A5052872662","https://openalex.org/A5053626099","https://openalex.org/A5055139947","https://openalex.org/A5057189669","https://openalex.org/A5059420340","https://openalex.org/A5069753479","https://openalex.org/A5089534178","https://openalex.org/A5111830456","https://openalex.org/A5113503287"],"corresponding_institution_ids":["https://openalex.org/I3019010403","https://openalex.org/I4210099034","https://openalex.org/I4210101691","https://openalex.org/I4210111317","https://openalex.org/I4210115949","https://openalex.org/I4210123675","https://openalex.org/I4210126200","https://openalex.org/I4210127641","https://openalex.org/I4210129357","https://openalex.org/I4210133602","https://openalex.org/I4210135003","https://openalex.org/I4210137674","https://openalex.org/I4210145084","https://openalex.org/I4210145506","https://openalex.org/I4210153139","https://openalex.org/I4210153460","https://openalex.org/I4210158561","https://openalex.org/I4210160075","https://openalex.org/I4210161852","https://openalex.org/I4392738196","https://openalex.org/I79238269","https://openalex.org/I88155538"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"132","issue":"Supplement 1","first_page":"433","last_page":"433"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.9520000219345093},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9129999876022339},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.9919999837875366},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.9179999828338623},{"id":"https://openalex.org/keywords/multiparameter-flow-cytometry","display_name":"multiparameter flow cytometry","score":0.7850000262260437},{"id":"https://openalex.org/keywords/fludarabine","display_name":"fludarabine","score":0.7649999856948853},{"id":"https://openalex.org/keywords/cytarabine","display_name":"cytarabine","score":0.9860000014305115},{"id":"https://openalex.org/keywords/azacitidine","display_name":"azacitidine","score":0.9800000190734863},{"id":"https://openalex.org/keywords/hypomethylating-agents","display_name":"hypomethylating agents","score":0.9169999957084656},{"id":"https://openalex.org/keywords/reduced-intensity-chemotherapy","display_name":"reduced-intensity chemotherapy","score":0.6230000257492065},{"id":"https://openalex.org/keywords/leukemia-associated-immunophenotype","display_name":"leukemia-associated immunophenotype","score":0.7710000276565552},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.6000000238418579},{"id":"https://openalex.org/keywords/cumulative-incidence-of-relapse","display_name":"cumulative incidence of relapse","score":0.6819999814033508},{"id":"https://openalex.org/keywords/treatment-de-escalation","display_name":"treatment de-escalation","score":0.5220000147819519}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8219723701477051},{"id":"https://openalex.org/C2778041864","wikidata":"https://www.wikidata.org/wiki/Q180983","display_name":"Cytarabine","level":3,"score":0.7324370741844177},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6279380321502686},{"id":"https://openalex.org/C2779263901","wikidata":"https://www.wikidata.org/wiki/Q185916","display_name":"Fludarabine","level":4,"score":0.6219574213027954},{"id":"https://openalex.org/C2779823535","wikidata":"https://www.wikidata.org/wiki/Q6865356","display_name":"Minimal residual disease","level":3,"score":0.5810363292694092},{"id":"https://openalex.org/C2776611710","wikidata":"https://www.wikidata.org/wiki/Q16888295","display_name":"Induction chemotherapy","level":3,"score":0.5549921989440918},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.5008554458618164},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.48812922835350037},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.47540387511253357},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.46085137128829956},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4601784944534302},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.4538671672344208},{"id":"https://openalex.org/C2776239401","wikidata":"https://www.wikidata.org/wiki/Q416451","display_name":"Azacitidine","level":5,"score":0.4413619041442871},{"id":"https://openalex.org/C2777198975","wikidata":"https://www.wikidata.org/wiki/Q5134875","display_name":"Clofarabine","level":4,"score":0.4126933515071869},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3657391667366028},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.1088876724243164},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2018-99-113299","doi":"https://doi.org/10.1182/blood-2018-99-113299","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-113299","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4389230134","https://openalex.org/W2134036993","https://openalex.org/W2019618063","https://openalex.org/W2790024202","https://openalex.org/W4389209165","https://openalex.org/W4367047766","https://openalex.org/W3213227101","https://openalex.org/W4229018428","https://openalex.org/W3095251964","https://openalex.org/W2594379076"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Incidence":[2],"of":[3,35,70,83,108,118,268,291,296,304,309,330,338,401,408,457,639],"AML":[4,42,97,110,383],"is":[5,14,620],"highest":[6],"among":[7,189,382,419,506,641],"the":[8,11,33,48,56,68,81,123,170,210,302,307,358,399,455,486,637,642],"elderly":[9,41],"and":[10,28,67,91,129,139,187,254,332,369,441,446,510,547,554,571,576,593,619,654],"general":[12],"outcome":[13,488],"poor":[15,467],"as":[16,63,315,388,468],"compared":[17,389,469],"to":[18,47,50,132,220,261,263,306,390,470],"young":[19],"patients,":[20],"even":[21],"those":[22,426,471,526],"who":[23],"tolerate":[24],"intensive":[25,54],"induction":[26,135,153,186],"chemotherapy":[27,102,403,633],"achieve":[29],"morphological":[30],"CR.":[31],"However,":[32],"role":[34,82],"MRD":[36,72,84,174,179,181,262,274,286,355,368,377,464,597,647],"in":[37,40,59,74,95,122,191,200,344,421,459,472,508,525,625],"redefining":[38],"CR":[39,192,305,326,345,422,460,509,618,663],"remains":[43,649],"poorly":[44],"investigated":[45],"due":[46],"reluctance":[49],"treat":[51],"them":[52],"with":[53,100,114,137,147,155,163,169,193,242,287,346,366,371,385,428,462,482,489,498,528,628,631,645],"chemotherapy,":[55],"renewed":[57],"interest":[58],"low-intensity":[60],"therapy":[61],"such":[62],"hypomethylating":[64],"agents":[65],"(HMA),":[66],"lack":[69],"molecular":[71],"markers":[73],"most":[75],"patients.":[76],"Aim:":[77],"To":[78],"help":[79],"defining":[80],"assessment":[85,616],"by":[86,143,159],"multidimensional":[87],"flow":[88],"cytometry":[89],"(MFC)":[90],"therapeutic":[92],"decision":[93],"making":[94],"older":[96,626],"patients":[98,111,167,190,324,343,384,420,443,458,481,507,573,627,644],"treated":[99,427,527,630],"semi-intensive":[101,402,632],"vs":[103,151,394,404,425,431,530,533],"HMA.":[104,635],"Methods:":[105],"A":[106],"total":[107],"285":[109],"(excluding":[112],"APL)":[113],"a":[115,201,227,265,316,353,412,517,599],"median":[116,565],"age":[117],"75":[119],"were":[120,130,230,240,282,379,444,465],"included":[121],"phase":[124],"III":[125],"PETHEMA-FLUGAZA":[126],"clinical":[127,206],"trial":[128],"randomized":[131],"receive":[133],"3":[134,152,328,336],"cycles":[136,146,154,162,329,337],"fludarabine":[138],"cytarabine":[140],"(FLUGA)":[141],"followed":[142,158],"6":[144,160],"consolidation":[145,161,188],"reduced":[148],"intensity":[149],"FLUGA,":[150,331],"5-azacitidine":[156],"(AZA)":[157],"AZA.":[164],"After":[165],"consolidation,":[166],"continued":[168],"same":[171],"treatment":[172],"if":[173,178],"\u22650.01%":[175],"or":[176,194,634],"stopped":[177],"<0.01%.":[180],"was":[182,218,299,574],"prospectively":[183],"assessed":[184],"after":[185,327,335,423,651],"without":[195,226,313],"incomplete":[196],"blood":[197],"count":[198],"recovery,":[199],"central":[202],"laboratory":[203],"blinded":[204],"for":[205,213,284,439,543,569,585,601],"outcomes.":[207],"At":[208,235],"diagnosis,":[209],"EuroFlow":[211],"panel":[212],"MDS/AML":[214],"(first-five":[215],"8-color":[216,244],"combinations)":[217],"used":[219],"identify":[221],"leukemia-associated":[222],"immunophenotypes":[223],"(LAIP).":[224],"Patients":[225],"LAIP":[228],"(6%)":[229],"excluded":[231],"from":[232,259,301],"this":[233],"analysis.":[234],"CR,":[236],"bone":[237],"marrow":[238],"samples":[239],"immunophenotyped":[241],"\u22652":[243],"combinations":[245],"based":[246],"on":[247,406],"previously":[248,347],"identified":[249,348],"maturation":[250],"arrest,":[251],"lineage":[252],"commitment":[253],"LAIPs,":[255],"maintaining":[256,660],"markers'":[257],"position":[258],"diagnosis":[260,272],"provide":[264],"digital":[266],"fingerprint":[267],"leukemic":[269],"blasts":[270],"at":[271,659],"during":[273],"assessment.":[275],"Over":[276],"1":[277],"million":[278],"events":[279],"per":[280],"tube":[281],"measured":[283],"assessing":[285],"an":[288,621,661],"estimated":[289],"sensitivity":[290],"0.01%.":[292],"The":[293,435,564],"cumulative":[294],"incidence":[295],"relapse":[297,314,640],"(CIR)":[298],"calculated":[300],"date":[303,308],"relapse,":[310],"considering":[311],"death":[312],"competing":[317],"event.":[318],"Results:":[319],"On":[320,540,582],"intention-to-treat,":[321],"38/141":[322],"(27%)":[323],"achieved":[325,352],"31/144":[333],"(21.5%)":[334],"AZA":[339,429,531],"(P":[340,580],"=.33).":[341],"Among":[342],"LAIP,":[349],"14/69":[350],"(20%)":[351],"negative":[354,376],"status":[356],"whereas":[357],"remaining":[359],"55":[360],"(80%)":[361],"had":[362],"persisting":[363],"MRD:":[364],"56%":[365],"\u22650.1%":[367],"24%":[370],"0.01%-0.09%":[372],"MRD.":[373],"Of":[374,453],"note,":[375,454],"rates":[378,418,438,494,515],"particularly":[380],"lower":[381],"myelodysplasia-related":[386],"changes":[387],"other":[391],"subtypes":[392],"(11%":[393],"27%,":[395],"respectively;":[396,433,535],"P=.09).":[397],"Regarding":[398],"effect":[400],"HMA":[405],"depth":[407],"response,":[409],"we":[410],"observed":[411],"non-significant":[413,518],"trend":[414,519,600],"toward":[415],"higher":[416,491],"MRD-negative":[417,442,572,662],"FLUGA":[424,529],"(26%":[430],"15%,":[432],"P=.28).":[434],"2-year":[436,492,513],"CIR":[437,456,493,514,544],"MRD-positive":[440,480,496,570],"88%":[445],"47%,":[447],"respectively":[448,579],"(HR,":[449,475,501,550,556,605],"3.3;":[450],"P":[451,477,503,538,552,558,607],"=.001).":[452],"but":[461],"persistent":[463,511,596],"similarly":[466],"partial":[473],"remission":[474],"0.82;":[476],"=.48).":[478],"Furthermore,":[479],"adverse":[483],"cytogenetics":[484,500,555],"displayed":[485],"poorest":[487],"significantly":[490],"than":[495],"cases":[497],"intermediate/favorable":[499],"2.1;":[502],"=.008).":[504],"Interestingly,":[505],"MRD,":[512],"showed":[516,598],"towards":[520],"slightly":[521],"more":[522],"frequent":[523],"relapses":[524],"(91%":[532],"77%,":[534],"HR,":[536],"1.7;":[537],"=.09).":[539],"multivariable":[541,583],"analysis":[542],"including":[545,587],"MFC-MRD":[546,549,615],"cytogenetics,":[548],"3.6;":[551],"=.001)":[553],"2.0;":[557],"=.007)":[559],"retained":[560],"significant":[561],"prognostic":[562,603,623],"value.":[563],"overall":[566],"survival":[567],"(OS)":[568],"17":[575],"29":[577],"months,":[578],"=.04).":[581],"analyses":[584],"OS":[586],"age,":[588],"WBC":[589],"count,":[590],"cytogenetic":[591],"grouping":[592],"secondary":[594],"disease,":[595],"independent":[602,622],"value":[604],"2.4;":[606],"=.07).":[608],"Conclusions:":[609],"This":[610],"study":[611],"reveals":[612],"that":[613],"sensitive":[614],"supersedes":[617],"factor":[624],"AML,":[629],"Nevertheless,":[636],"risk":[638],"few":[643],"no":[646],"(5%)":[648],"high":[650],"stopping":[652],"treatment,":[653],"warrants":[655],"innovative":[656],"approaches":[657],"aimed":[658],"status.":[664],"Disclosures":[665],"San-Miguel:":[666],"Janssen:":[667],"Honoraria;":[668,670,672,674,676,678],"BMS:":[669],"Novartis:":[671],"Celgene:":[673],"Amgen:":[675],"Sanofi:":[677],"Roche:":[679],"Honoraria.":[680],"Montesinos:Novartis:":[681],"Research":[682],"Funding,":[683],"Speakers":[684,689],"Bureau;":[685],"Daiichi":[686],"Sankyo:":[687],"Consultancy,":[688],"Bureau.":[690]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1}],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2025-10-10T00:00:00"}